Fosun Pharma

Founded 1994


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 21
Average round size
The average size of a deal this fund participated in
Portfolio companies 21
Rounds per year 0.78
Lead investments 7
Exits 7
Key employees 14

Areas of investment

  • Health Care
  • Biotechnology
  • Pharmaceutical
  • Medical
  • Medical Device

The fund has exact preference in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. Among the most popular fund investment industries, there are Biopharma, Medical. Among the most popular portfolio startups of the fund, we may highlight Butterfly Network, Yaoshibang, Check-Cap. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.

We also calculated 14 valuable employees in our database.

The usual things for fund are deals in the range of 10 - 50 millions dollars. Considering the real fund results, this Corporate Investor is 47 percentage points more often commits exit comparing to other organizations. The fund is generally included in less than 2 deals every year. The increased amount of exits for fund were in 2015. The important activity for fund was in 2018.

The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Fosun Pharma, startups are often financed by UFG Private Equity, Simul Investments, Pittsburgh Life Sciences Greenhouse. The meaningful sponsors for the fund in investment in the same round are South Valley Angels, Pontifax, Ohio Innovation Fund. In the next rounds fund is usually obtained by Green Pine Capital Partners, DCM Ventures, Yijing Capital.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Fosun Pharma:
Typical Co-investors
Fosun Pharma is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Fosun Pharma:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Reflect Ventures -
Boston Impact Initiative United States, Jamaica Plain
Harwick Overseas -
Inheritance Enterprises Russia, Moscow
CITIC Guoan Group Corporation China, Beijing
TechGains Funds -
SG Hiscock -
Chipotle Mexican Grill United States, Denver
Minmetals Capital China, Haidian
Ningbo Meishan Baoshui Gangqu Saiyi Boying Touzi Guanli Zhongxin China, Ningbo
Nisshinbo Holdings Japan, Tokyo
Pathfinder Venture Capital Funds United States, Minneapolis
Tekla Capital Management United States, Boston
Ericsson-Deutsche Technology Fund Australia, Sydney
Teknologisk Innovation AS Denmark, Tåstrup
Ziff Davis United States, New York
iGlobe Partners Russia, Moscow
T2 Venture Creation United States, Portola Valley
Boat Rocker Ventures United States, Santa Monica
Rider Global Cyprus, Limassol

Notable deals

CompanyIndustryRoundRound SizeDateInvestorsLocation

Gyroscope Therapeutics

Health Care
$147M26 Mar 2021 United Kingdom, " United Kingdom"}

Fosun Kite Biotechnology

$20M09 Jul 2020 China, Shanghai

Health Care
$40M31 Jul 2019 China, Qingyang District

EOS Imaging

3D Technology
Health Care
Medical Device
$17M10 Dec 2018 France, Paris


Health Care
$10M23 Oct 2018 United States, New York

Butterfly Network

Health Care
Medical Device
Personal Health
$250M27 Sep 2018 United States, " United States"}

Health Care
Nursing and Residential Care
26 Sep 2018 China, Shanghai


Health Care
$14M06 Aug 2018 China, Dongcheng District

Shanghai Henlius Biotech

Health Care
$190M22 Dec 2017 China, Shanghai


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Fosun Pharma?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Crunchbase icon

Content report

The following text will be sent to our editors: